Comparison of the effects of recombinant adenovirus-mediated expression of wild-type p53 and p27Kip1 on cell cycle and apoptosis in SUDHL-1 cells derived from anaplastic large cell lymphoma

Leukemia

Volumn 15, Issue 8, 2001, Pages 1225-1231

  Turturro, F ^a,b   Frist, A Y ^a   Arnold, M D ^a   Pal, A ^a   Cook, G A ^a   Seth, P ^c  

^a Iowa Cancer Research Foundation   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DES MOINES UNIVERSITY   (United States)

Author keywords

Adenovirus; Apoptosis; Cell cycle; Cyclin dependent kinase inhibitor; p27Kip1; p53

Indexed keywords

PROTEIN P27; PROTEIN P53; VIRUS VECTOR;

ADENOVIRUS; ANAPLASTIC CARCINOMA; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL POPULATION; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LYMPHOMA CELL LINE; NICK END LABELING; PRIORITY JOURNAL; STEADY STATE; VIRUS INFECTION; VIRUS RECOMBINANT;

EID: 0034891635     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402181     Document Type: Article

References (32)

1. Cell cycle and apoptosis: Common pathways to life and death
2. p53, the cellular gatekeeper for growth and division
3. Sequence-specific transcriptional activation is essential for growth suppression by p53
4. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors
5. p53: Puzzle and paradigm
6. WAF1, a potential mediator of p53 tumor suppression
7. 5 integrin in SUDHL-1 cells derived from anaplastic large cell lymphoma
8. A recombinant adenovirus expressing p27kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells
9. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27
10. KIP1 in inducing cell cycle arrest, tumorigenicity
11. Kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
12. Cyclic AMP-induced G1 arrest mediated by an inhibitor (p27kip1) of cyclin-dependent kinase 4 activation
13. Inactivation of a Cdk2 inhibitor during interleukin-2 induced proliferation of human T lymphocytes
14. Kip1 for restriction point control of the fibroblast cell cycle
15. Alterations of the p27/kip1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma
16. P27/kip1 mutation found in breast cancer
17. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells
18. DNA content histogram and cell-cycle analysis
19. kip1 mediates apoptosis in endothelial cells through activation of Cdk2: Role of a caspase cascade
20. CyclinE-CDK2 is a regulator of p27kip1
21. kip1 down regulation, passage through the restriction point and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts
22. The Pezcoller Lecture: Cancer cell cycles revisited
23. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma study group
24. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK
25. Fusion of a kinase gene ALK, to a nuclear protein gene, NPM, in non-Hodgkin's lymphoma
26. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis
27. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice
28. Chronic myelomonocytic leukemia: Tela-kinase what Ets all about
29. kip1 through the phosphatidylinositol 3-kinase/AKT pathway
30. Kip, which is relocated to the cell cytoplasm and regulating cdk2 activity
31. kip1 and its alterations in tumor cells: A review
32. Adenovirus-p53-mediated gene therapy of anaplastic large cell lymphoma with t(2;5) in a nude mouse model